Literature DB >> 28052200

Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439).

Yuxiang Dong1, Xiaofang Wang1, Sriraghavan Kamaraj1, Vivek J Bulbule1, Francis C K Chiu2, Jacques Chollet3,4, Manickam Dhanasekaran1, Christopher D Hein1, Petros Papastogiannidis3,4, Julia Morizzi2, David M Shackleford2, Helena Barker2, Eileen Ryan2, Christian Scheurer3,4, Yuanqing Tang1, Qingjie Zhao1, Lin Zhou1, Karen L White2, Heinrich Urwyler5, William N Charman2, Hugues Matile6, Sergio Wittlin3,4, Susan A Charman2, Jonathan L Vennerstrom1.   

Abstract

Building on insights gained from the discovery of the antimalarial ozonide arterolane (OZ277), we now describe the structure-activity relationship (SAR) of the antimalarial ozonide artefenomel (OZ439). Primary and secondary amino ozonides had higher metabolic stabilities than tertiary amino ozonides, consistent with their higher pKa and lower log D7.4 values. For primary amino ozonides, addition of polar functional groups decreased in vivo antimalarial efficacy. For secondary amino ozonides, additional functional groups had variable effects on metabolic stability and efficacy, but the most effective members of this series also had the highest log D7.4 values. For tertiary amino ozonides, addition of polar functional groups with H-bond donors increased metabolic stability but decreased in vivo antimalarial efficacy. Primary and tertiary amino ozonides with cycloalkyl and heterocycle substructures were superior to their acyclic counterparts. The high curative efficacy of these ozonides was most often associated with high and prolonged plasma exposure, but exposure on its own did not explain the presence or absence of either curative efficacy or in vivo toxicity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28052200     DOI: 10.1021/acs.jmedchem.6b01586

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

1.  Antimalarial Trioxolanes with Superior Drug-Like Properties and In Vivo Efficacy.

Authors:  Brian R Blank; Ryan L Gonciarz; Poulami Talukder; Jiri Gut; Jennifer Legac; Philip J Rosenthal; Adam R Renslo
Journal:  ACS Infect Dis       Date:  2020-05-18       Impact factor: 5.084

2.  Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids.

Authors:  Jianbo Wu; Xiaofang Wang; Francis C K Chiu; Cécile Häberli; David M Shackleford; Eileen Ryan; Sriraghavan Kamaraj; Vivek J Bulbule; Alexander I Wallick; Yuxiang Dong; Karen L White; Paul H Davis; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2020-03-19       Impact factor: 7.446

3.  Lowering Lipophilicity by Adding Carbon: AzaSpiroHeptanes, a logD Lowering Twist.

Authors:  Sébastien L Degorce; Michael S Bodnarchuk; James S Scott
Journal:  ACS Med Chem Lett       Date:  2019-07-18       Impact factor: 4.345

4.  Therapeutic efficacy of antimalarial drugs targeting DosRS signaling in Mycobacterium abscessus.

Authors:  Juan Manuel Belardinelli; Deepshikha Verma; Wei Li; Charlotte Avanzi; Crystal J Wiersma; John T Williams; Benjamin K Johnson; Matthew Zimmerman; Nicholas Whittel; Bhanupriya Angala; Han Wang; Victoria Jones; Véronique Dartois; Vinicius C N de Moura; Mercedes Gonzalez-Juarrero; Camron Pearce; Alan R Schenkel; Kenneth C Malcolm; Jerry A Nick; Susan A Charman; Timothy N C Wells; Brendan K Podell; Jonathan L Vennerstrom; Diane J Ordway; Robert B Abramovitch; Mary Jackson
Journal:  Sci Transl Med       Date:  2022-02-23       Impact factor: 19.319

5.  Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.

Authors:  Yiping Wang; Rupkatha Mukhopadhyay; Sujayita Roy; Arun Kapoor; Yu-Pin Su; Susan A Charman; Gong Chen; Jianbo Wu; Xiaofang Wang; Jonathan L Vennerstrom; Ravit Arav-Boger
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 6.  Ferrous Iron-Dependent Pharmacology.

Authors:  Ryan L Gonciarz; Eric A Collisson; Adam R Renslo
Journal:  Trends Pharmacol Sci       Date:  2020-11-28       Impact factor: 14.819

Review 7.  Increasing the Strength and Production of Artemisinin and Its Derivatives.

Authors:  Syed Lal Badshah; Asad Ullah; Nasir Ahmad; Zainab M Almarhoon; Yahia Mabkhot
Journal:  Molecules       Date:  2018-01-03       Impact factor: 4.411

8.  Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads.

Authors:  Manu Anantpadma; Thomas Lane; Kimberley M Zorn; Mary A Lingerfelt; Alex M Clark; Joel S Freundlich; Robert A Davey; Peter B Madrid; Sean Ekins
Journal:  ACS Omega       Date:  2019-01-30

9.  Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.

Authors:  Malinda Salim; Jamal Khan; Gisela Ramirez; Mubtasim Murshed; Andrew J Clulow; Adrian Hawley; Hanu Ramachandruni; Stephane Beilles; Ben J Boyd
Journal:  Mol Pharm       Date:  2019-03-04       Impact factor: 4.939

10.  Cytochrome P450-Mediated Metabolism and CYP Inhibition for the Synthetic Peroxide Antimalarial OZ439.

Authors:  David M Shackleford; Francis C K Chiu; Kasiram Katneni; Scott Blundell; Jenna McLaren; Xiaofang Wang; Lin Zhou; Kamaraj Sriraghavan; André M Alker; Daniel Hunziker; Christian Scheurer; Qingjie Zhao; Yuxiang Dong; Jörg J Möhrle; Nada Abla; Hugues Matile; Sergio Wittlin; Jonathan L Vennerstrom; Susan A Charman
Journal:  ACS Infect Dis       Date:  2021-06-08       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.